- FAST1 Device
- Dieckmann Modified Needle
- BIG Device
- EZ-IO Device
- Jamshidi Needle
- FASTx Device
Intraosseous Infusion Devices Market size is valued at USD 943.2 million in 2021, growing at a CAGR of 5.6% from 2022 to 2028. The global market provides a detailed overview of the Intraosseous Infusion Devices market and which can be segmented by product type, technology, route of administration, the end user. By product type, the Intraosseous Infusion Devices market has been segmented into FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, FASTx Device, and NIO. By product type, the FASTx device segment held the largest revenue share of the intraosseous infusion devices market in past years and is expected to have the fastest growth rate over the forecasted period due to having more accuracy and precision in getting results. The FASTx intraosseous infusion device provides a sternal intraosseous access route to patients when standard venous access is not possible. Using the sternal IO access route, providers can rapidly deliver lifesaving fluids and medications1-3 to facilitate emergency resuscitation through the bone marrow space. FASTx can be effectively used during CPR and when a cervical spine collar is in place. By technology, the Intraosseous Infusion Devices market has been segmented into technology (battery-powered drivers, manual io needles, and impact driven devices. By technology, the impact driven devices segment is expected to have the fastest growth rate over the forecasted period due to continuous advancement in the device. Impact driven devices for penetrating bone marrow of a bone is provided. The apparatus includes a housing comprising a handle and a trigger mechanism, a spring-loaded assembly comprising a rod and a shaft; and a connector comprising a first end operable to connect to the drive shaft and a second end operable to attach to a penetrator hub. The penetrator hub includes a penetrator operable to access the bone marrow. By route of administration, the Intraosseous Infusion Devices market has been segmented into the distal femur, sternum, distal and proximal tibia, calcaneus, and head of humerus. Based on the route of administration, the sternum segment is expected to have a progressive growth rate over the forecasted period. Sternum, clavicle, humeral head, iliac crest, distal femur, proximal tibia, distal tibia, and calcaneus are all potential sites for intraosseous access. Additionally, the sternum site is mainly for adults. Â Based on the end user, the segment has been segregated into hospitals, emergency medical services, ambulatory surgical centers, and cardiac care centers. Based on End Users, the Hospitals segment holds the largest growth during the projected period, the Cardiac Care segment is expected to expand rapidly in terms of sales. Key Development: In June 2022, Becton Dickinson is recalling a range of products used to deliver fluids and medications during resuscitations and life-saving procedures because of problems that could lead to patient deaths.
Fastest Growing Market
The primary focus of emergency settings is to stabilize the patient from a life-threatening event and refer them to a primary healthcare center immediately for further desired medical intervention. For this, governmental bodies across various countries around the world are prioritizing emergency attention for increasing healthcare standards and improving in standards of pre-hospital emergency settings in developing countries. These are some major factors that drive the intraosseous infusion device market growth.
The global Intraosseous Infusion Devices market size is valued at USD 943.2 million in 2021 and is expected to grow at a CAGR of 5.6% during the forecast period 2022 to 2028. Rising incidences of vascular diseases worldwide, and increasing adoption of vascular devices. Further, an increase in disease burden and approval of pipeline candidates are expected to fuel the growth of the market during the forecast period.
The global intraosseous infusion device market is expected to be driven by the increasing demand for vascular access devices and quality emergency care.
Based on product type, The FAST1 device now leads the market and is expected to do so during the projected period. Medical's FAST1 Intraosseous infusion technology is extensive in usage in military medical care facilities in circumstances of personal combat and military crises.
The North American region currently leads the worldwide market and is likely to continue to do so over the forecast period. The high prevalence of cardiovascular diseases, chronic illnesses, emergency medical situations, and obesity all contribute significantly to the regional market's growth.